Showing results (141-150 of 273) with videos related to

Sort By:
Pageof 28
Cells|November 11, 2022
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic AdenocarcinomaCristina Di Giorgio, Antonio Lupia, Silvia Marchianò, et al.
Nature Reviews. Drug Discovery|July 18, 2002
Potential cardioprotective actions of no-releasing aspirinJohn L Wallace, Louis J Ignarro, Stefano Fiorucci
Cardiovascular Drug Reviews|June 5, 2004
Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current statusStefano Fiorucci, Elisabetta Antonelli, Paola Tocchetti, et al.
Future Medicinal Chemistry|May 11, 2012
Farnesoid X receptor: from medicinal chemistry to clinical applicationsStefano Fiorucci, Andrea Mencarelli, Elenora Distrutti, et al.
Biochimica Et Biophysica Acta|April 28, 2009
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophagesBarbara Renga, Marco Migliorati, Andrea Mencarelli, et al.
Journal of Lipid Research|September 29, 2009
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese ratsSabrina Cipriani, Andrea Mencarelli, Giuseppe Palladino, et al.
Progress in Lipid Research|November 26, 2009
Bile acid-activated receptors in the treatment of dyslipidemia and related disordersStefano Fiorucci, Sabrina Cipriani, Franco Baldelli, et al.
Trends in Pharmacological Sciences|September 18, 2009
Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disordersStefano Fiorucci, Andrea Mencarelli, Giuseppe Palladino, et al.
Marine Drugs|May 26, 2023
Theonella: A Treasure Trove of Structurally Unique and Biologically Active SterolsCarmen Festa, Simona De Marino, Angela Zampella, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 19, 2005
Lipoxins in gastric mucosal health and diseaseJohn L Wallace, Octavio Menezes de Lima, Stefano Fiorucci
Pageof 28